259 related articles for article (PubMed ID: 18703014)
1. Downregulation of muscle protein degradation in sepsis by eicosapentaenoic acid (EPA).
Khal J; Tisdale MJ
Biochem Biophys Res Commun; 2008 Oct; 375(2):238-40. PubMed ID: 18703014
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of ubiquitin-dependent protein degradation in murine myotubes during hyperthermia by eicosapentaenoic acid.
Smith HJ; Khal J; Tisdale MJ
Biochem Biophys Res Commun; 2005 Jun; 332(1):83-8. PubMed ID: 15896302
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of ubiquitin-dependent proteolysis by eicosapentaenoic acid in acute starvation.
Whitehouse AS; Tisdale MJ
Biochem Biophys Res Commun; 2001 Jul; 285(3):598-602. PubMed ID: 11453634
[TBL] [Abstract][Full Text] [Related]
4. Muscle wasting in a rat model of long-lasting sepsis results from the activation of lysosomal, Ca2+ -activated, and ubiquitin-proteasome proteolytic pathways.
Voisin L; Breuillé D; Combaret L; Pouyet C; Taillandier D; Aurousseau E; Obled C; Attaix D
J Clin Invest; 1996 Apr; 97(7):1610-7. PubMed ID: 8601625
[TBL] [Abstract][Full Text] [Related]
5. Attenuation of proteasome-induced proteolysis in skeletal muscle by {beta}-hydroxy-{beta}-methylbutyrate in cancer-induced muscle loss.
Smith HJ; Mukerji P; Tisdale MJ
Cancer Res; 2005 Jan; 65(1):277-83. PubMed ID: 15665304
[TBL] [Abstract][Full Text] [Related]
6. Induction of protein degradation in skeletal muscle by a phorbol ester involves upregulation of the ubiquitin-proteasome proteolytic pathway.
Wyke SM; Tisdale MJ
Life Sci; 2006 May; 78(25):2898-910. PubMed ID: 16343552
[TBL] [Abstract][Full Text] [Related]
7. The ubiquitin-proteasome pathway as a therapeutic target for muscle wasting.
Tisdale MJ
J Support Oncol; 2005; 3(3):209-17. PubMed ID: 15915823
[TBL] [Abstract][Full Text] [Related]
8. The ubiquitin-proteasome proteolytic pathway in heart vs skeletal muscle: effects of acute diabetes.
Liu Z; Miers WR; Wei L; Barrett EJ
Biochem Biophys Res Commun; 2000 Oct; 276(3):1255-60. PubMed ID: 11027619
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of proteasome subunits in skeletal muscle of cancer patients with weight loss.
Khal J; Hine AV; Fearon KC; Dejong CH; Tisdale MJ
Int J Biochem Cell Biol; 2005 Oct; 37(10):2196-206. PubMed ID: 16125116
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of attenuation of skeletal muscle protein catabolism in cancer cachexia by eicosapentaenoic acid.
Whitehouse AS; Smith HJ; Drake JL; Tisdale MJ
Cancer Res; 2001 May; 61(9):3604-9. PubMed ID: 11325828
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy inhibits skeletal muscle ubiquitin-proteasome-dependent proteolysis.
Tilignac T; Temparis S; Combaret L; Taillandier D; Pouch MN; Cervek M; Cardenas DM; Le Bricon T; Debiton E; Samuels SE; Madelmont JC; Attaix D
Cancer Res; 2002 May; 62(10):2771-7. PubMed ID: 12019153
[TBL] [Abstract][Full Text] [Related]
12. Ubiquitin-proteasome-dependent proteolytic activity remains elevated after zymosan-induced sepsis in rats while muscle mass recovers.
Minnaard R; Wagenmakers AJ; Combaret L; Attaix D; Drost MR; van Kranenburg GP; Schaart G; Hesselink MK
Int J Biochem Cell Biol; 2005 Oct; 37(10):2217-25. PubMed ID: 15955721
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms activating proteolysis to cause muscle atrophy in catabolic conditions.
Mitch WE; Price SR
J Ren Nutr; 2003 Apr; 13(2):149-52. PubMed ID: 12671840
[TBL] [Abstract][Full Text] [Related]
14. Induction of protein catabolism in myotubes by 15(S)-hydroxyeicosatetraenoic acid through increased expression of the ubiquitin-proteasome pathway.
Whitehouse AS; Khal J; Tisdale MJ
Br J Cancer; 2003 Aug; 89(4):737-45. PubMed ID: 12915888
[TBL] [Abstract][Full Text] [Related]
15. The ubiquitin-proteasome and the mitochondria-associated apoptotic pathways are sequentially downregulated during recovery after immobilization-induced muscle atrophy.
Vazeille E; Codran A; Claustre A; Averous J; Listrat A; BĂ©chet D; Taillandier D; Dardevet D; Attaix D; Combaret L
Am J Physiol Endocrinol Metab; 2008 Nov; 295(5):E1181-90. PubMed ID: 18812460
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of attenuation of protein loss in murine C2C12 myotubes by D-myo-inositol 1,2,6-triphosphate.
Russell ST; Siren PM; Siren MJ; Tisdale MJ
Exp Cell Res; 2010 Jan; 316(2):286-95. PubMed ID: 19716818
[TBL] [Abstract][Full Text] [Related]
17. Novel aspects on the regulation of muscle wasting in sepsis.
Hasselgren PO; Menconi MJ; Fareed MU; Yang H; Wei W; Evenson A
Int J Biochem Cell Biol; 2005 Oct; 37(10):2156-68. PubMed ID: 16125115
[TBL] [Abstract][Full Text] [Related]
18. The 'cancer cachectic factor'.
Tisdale MJ
Support Care Cancer; 2003 Feb; 11(2):73-8. PubMed ID: 12560934
[TBL] [Abstract][Full Text] [Related]
19. Role of ubiquitin-proteasome pathway in skeletal muscle wasting in rats with endotoxemia.
Chai J; Wu Y; Sheng ZZ
Crit Care Med; 2003 Jun; 31(6):1802-7. PubMed ID: 12794423
[TBL] [Abstract][Full Text] [Related]
20. [Effect of sepsis on the expression of ubiquitin and ubiquitinated protein in rat skeletal muscle].
Chai J; Wu Y; Sheng Z
Zhonghua Wai Ke Za Zhi; 2001 Sep; 39(9):721-3. PubMed ID: 11769613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]